Genital warts and HIV infection in high-risk women in Burkina Faso
Author Information
Author(s): Andrea J Low, Tim Clayton, Issouf Konate, Nicolas Nagot, Abdoulaye Ouedraogo, Charlotte Huet, Marie-Noelle Didelot-Rousseau, Michel Segondy, Philippe Van de Perre, Philippe Mayaud
Primary Institution: London School of Hygiene & Tropical Medicine
Hypothesis
What are the risk factors for genital warts in high-risk women in Burkina Faso?
Conclusion
Genital warts occur much more frequently among HIV-1 infected women in Africa, especially those with low CD4+ counts.
Supporting Evidence
- Genital wart prevalence was 1.6% among HIV-uninfected and 7.0% among HIV-1 seropositive women.
- Incident genital warts were associated with concurrent bacterial vaginosis and genital ulceration.
- Antiretroviral therapy did not protect against incident or persistent genital warts.
Takeaway
This study found that women with HIV have more genital warts, especially if their immune system is weak.
Methodology
A prospective study of 765 high-risk women followed for 27 months, assessing genital warts and HIV status.
Potential Biases
Potential underreporting of genital warts if women sought treatment elsewhere.
Limitations
The study had varying time between visits and broad anatomical categorizations, which may have led to underestimates of incidence.
Participant Demographics
Women aged 16 years or older, with a history of transactional sex, primarily from Burkina Faso.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 1.97 to 14.40
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website